Pages that link to "Q37082640"
Jump to navigation
Jump to search
The following pages link to Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism (Q37082640):
Displaying 50 items.
- The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms - an appraisal (Q33662740) (← links)
- Introduction to the human gut microbiota (Q33693158) (← links)
- Distinct patterns in the gut microbiota after surgical or medical therapy in obese patients (Q33824299) (← links)
- Significance of Microbiota in Obesity and Metabolic Diseases and the Modulatory Potential by Medicinal Plant and Food Ingredients (Q33858968) (← links)
- Taurine does not affect the composition, diversity, or metabolism of human colonic microbiota simulated in a single-batch fermentation system (Q33897850) (← links)
- High-Quality Draft Genome Sequence of Lactobacillus casei Strain Z11, Isolated from a Human Adult Intestinal Biopsy Sample (Q33907151) (← links)
- Comparative study on the in vitro effects of Pseudomonas aeruginosa and seaweed alginates on human gut microbiota (Q36272931) (← links)
- Metabolites: messengers between the microbiota and the immune system (Q37151353) (← links)
- Randomised clinical study: inulin short-chain fatty acid esters for targeted delivery of short-chain fatty acids to the human colon. (Q37261858) (← links)
- Fecal Short-Chain Fatty Acid Variations by Breastfeeding Status in Infants at 4 Months: Differences in Relative versus Absolute Concentrations (Q37743096) (← links)
- Determination of Resistant Starch Assimilating Bacteria in Fecal Samples of Mice by In vitro RNA-Based Stable Isotope Probing. (Q38645160) (← links)
- Fecal microbiota transplantation in inflammatory bowel disease: the quest for the holy grail (Q38909454) (← links)
- The infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases (Q38911712) (← links)
- Formation of propionate and butyrate by the human colonic microbiota (Q39032599) (← links)
- Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet. (Q39180593) (← links)
- Regulation of intestinal permeability: The role of proteases (Q39239228) (← links)
- Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (Q39381331) (← links)
- Metabolic orchestration of T lineage differentiation and function (Q40049632) (← links)
- Probiotic mixture VSL#3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice. (Q40447506) (← links)
- Stool consistency is significantly associated with pain perception (Q41326438) (← links)
- Gut microbial metabolites in health and disease (Q42006171) (← links)
- Branched short-chain fatty acids modulate glucose and lipid metabolism in primary adipocytes. (Q42115138) (← links)
- Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease (Q42677255) (← links)
- Effects of Antidiabetic Drugs on Gut Microbiota Composition (Q46295791) (← links)
- Polyphenols and health: Interactions between fibre, plant polyphenols and the gut microbiota. (Q47114175) (← links)
- A look at the smelly side of physiology: transport of short chain fatty acids. (Q47228407) (← links)
- Early Origins of Asthma: Role of Microbial Dysbiosis and Metabolic Dysfunction (Q47607410) (← links)
- Gamma-Aminobutyric Acid Increases the Production of Short-Chain Fatty Acids and Decreases pH Values in Mouse Colon (Q47788516) (← links)
- Acute oral sodium propionate supplementation raises resting energy expenditure and lipid oxidation in fasted humans. (Q47841222) (← links)
- Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease. (Q47899492) (← links)
- The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis (Q48047320) (← links)
- The Biochemistry of Sensing: Enteric Pathogens Regulate Type III Secretion in Response to Environmental and Host Cues. (Q48232558) (← links)
- Low amounts of dietary fibre increase in vitro production of short-chain fatty acids without changing human colonic microbiota structure. (Q48262966) (← links)
- Fructo-oligosaccharides and glucose homeostasis: a systematic review and meta-analysis in animal models. (Q49166800) (← links)
- Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer, Obesity and Insulin Resistance (Q49205960) (← links)
- Effects of HLA-B27 on Gut Microbiota in Experimental Spondyloarthritis Implicate an Ecological Model of Dysbiosis (Q49491551) (← links)
- Flavonoids, Dairy Foods, and Cardiovascular and Metabolic Health: A Review of Emerging Biologic Pathways. (Q49953600) (← links)
- The Effect of Oligofructose-Enriched Inulin on Faecal Bacterial Counts and Microbiota-Associated Characteristics in Celiac Disease Children Following a Gluten-Free Diet: Results of a Randomized, Placebo-Controlled Trial (Q50033816) (← links)
- In Vivo Assessment of Resistant Starch Degradation by the Caecal Microbiota of Mice Using RNA-Based Stable Isotope Probing-A Proof-of-Principle Study. (Q50055181) (← links)
- Transglycosylated Starch Modulates the Gut Microbiome and Expression of Genes Related to Lipid Synthesis in Liver and Adipose Tissue of Pigs. (Q50356230) (← links)
- Synthesized enone fatty acids resembling metabolites from gut microbiota suppress macrophage-mediated inflammation in adipocytes. (Q50980091) (← links)
- Bioengineered Systems and Designer Matrices That Recapitulate the Intestinal Stem Cell Niche. (Q52314668) (← links)
- Gut microbiota as a source of novel antimicrobials. (Q52628118) (← links)
- A Walnut-Enriched Diet Affects Gut Microbiome in Healthy Caucasian Subjects: A Randomized, Controlled Trial. (Q52690219) (← links)
- Microbial metabolites, short-chain fatty acids, restrain tissue bacterial load, chronic inflammation, and associated cancer in the colon of mice. (Q53074277) (← links)
- Resistant starch reduces large intestinal pH and promotes fecal lactobacilli and bifidobacteria in pigs. (Q53684894) (← links)
- Microbiota and metabolic diseases. (Q53688571) (← links)
- Immune regulation by microbiome metabolites. (Q54250172) (← links)
- Pushing the Limits of Cancer Therapy: The Nutrient Game. (Q54959664) (← links)
- A combination of Lactobacillus mali APS1 and dieting improved the efficacy of obesity treatment via manipulating gut microbiome in mice. (Q54963689) (← links)